Takhzyro Solution
Product Images NDC 47783-646

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 44 technical images submitted to the FDA as part of the official labeling for Takhzyro (NDC 47783-646). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Takeda Pharmaceuticals America, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure (Lanadelumab 01)

Figure (Lanadelumab 01)
This text appears to describe components of a syringe, including a syringe barrel, a plunger rod, a stopper, a medicine needle cap, and a finger grip. The finger grip is noted to be important to keep on at all times.*
FDA Label Image

Figure (Lanadelumab 02)

FDA Label Image

Figure (Lanadelumab 03)

FDA Label Image

Figure (Lanadelumab 04)

FDA Label Image

Figure (Lanadelumab 05)

FDA Label Image

Figure (Lanadelumab 06)

FDA Label Image

Figure (Lanadelumab 07)

FDA Label Image

Figure (Lanadelumab 08)

FDA Label Image

Figure (Lanadelumab 09)

FDA Label Image

Figure (Lanadelumab 10)

FDA Label Image

Figure (Lanadelumab 11)

FDA Label Image

Figure (Lanadelumab 12)

FDA Label Image

Figure (Lanadelumab 13)

FDA Label Image

Figure (Lanadelumab 14)

FDA Label Image

Figure (Lanadelumab 15)

Figure (Lanadelumab 15)
The text appears to be a description of a part of a syringe. Specifically, it mentions the bottom of the barrel and a stopper with the letter "M8" on it. However, without more context, it is difficult to discern the exact purpose or function of this component.*
FDA Label Image

Figure (Lanadelumab 16)

FDA Label Image

Figure (Lanadelumab 17)

FDA Label Image

Figure (Lanadelumab 18)

FDA Label Image

Figure (Lanadelumab 19)

FDA Label Image

Figure (Lanadelumab 20)

Figure (Lanadelumab 20)
A plunger is a tool used to create suction and clear blockages in drains and pipes. It typically consists of a rubber cup attached to a stick-like handle. When the cup is pushed down over the drain or pipe opening and pushed back up, it creates suction that can dislodge and remove clogs. Plungers are commonly used in bathrooms and kitchens for clearing sink, toilet, and bathtub drains.*
FDA Label Image

Figure (Lanadelumab 21)

Figure (Lanadelumab 21)
This appears to be an incomplete list of three components related to a needle assembly - a hub, a cap, and a needle itself. Without additional context or information, it is not possible to provide a more precise or useful description.*
FDA Label Image

Figure (Lanadelumab 22)

Figure (Lanadelumab 22)
This appears to be a brief description of some components of a hypodermic needle, including the needle itself, a hub which could connect the needle to a syringe, and a cap which presumably covers the sharp point of the needle for sanitary reasons.*
FDA Label Image

Figure (Lanadelumab 23)

FDA Label Image

Figure (Lanadelumab 24)

FDA Label Image

Figure (Lanadelumab 25)

FDA Label Image

Figure (Lanadelumab 26)

FDA Label Image

Principal Display Panel (2 mL Vial Carton)

FDA Label Image

Lanadelumab 28

FDA Label Image

Lanadelumab 29

FDA Label Image

Lanadelumab 30

FDA Label Image

Lanadelumab 31

FDA Label Image

Lanadelumab 32

FDA Label Image

Lanadelumab 33

FDA Label Image

Lanadelumab 34

FDA Label Image

Lanadelumab 35

FDA Label Image

Lanadelumab 36

FDA Label Image

Lanadelumab 37

FDA Label Image

Lanadelumab 38

FDA Label Image

Lanadelumab 39

FDA Label Image

Lanadelumab 40

FDA Label Image

Lanadelumab 41

FDA Label Image

Lanadelumab 42

FDA Label Image

Lanadelumab 43

Lanadelumab 43
Description: STAKHZYRO is a injection used for subcutaneous administration. It is a prefilled syringe containing 300 mg/2 ml of anadelumab-fiyo. It is available in a pack of 4 single-dose pre-filled syringes. The instructions for use must be read prior to administering the medicine. The syringe must be held properly, and the needle cap should not be removed until ready to inject. The plunger rod should not be touched or pushed until ready to inject. Some illegible characters are present in the text.*
FDA Label Image

Lanadelumab 44

Lanadelumab 44
TAKHZYRO is the brand name of an injection medication called lanadelumab-fiyo. It is typically used for the prevention of swelling attacks in patients with hereditary angioedema. The medication comes in a pre-filled syringe, and dosage is determined by a medical professional.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.